FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891027998> ?p ?o ?g. }

• W2891027998 abstract "INTRODUCTION: Tuberculosis is a major disease causing death every year 1.8 million worldwide and represents the leading cause of mortality resulting from a bacterial infection. Introduction in the 60’s of first-line drug regimen resulted in the control of the disease and TB was perceived as defeated.In 2011, tuberculosis (TB) remained the second cause of death from infectious disease worldwide. It mainly affects the poorest countries of Africa andSoutheast Asia. In 2010, according to the world health organization (WHO), TB incidence and prevalence were estimated at 8.8 and 12 million cases respectivelyabout 1.1 million among HIV-negative people and 0.35 million among HIV-positive people died from TB. Most importantly, one third of the world population is infectedwith latent infection and 10% of those infected people will develop active TB in their life. BACTERIOLOGICAL PROFILE OF MYCOBACTERIUM TUBERCULOSIS SPECIES: The mycobacterium tuberculosis complex consists of Mycobacterium bovis,Mycobacterium africanoum and Mycobacterium canettii, Mycobacterium capre, Mycobacterium microti and Mycobacterium pinnipedi. Tuberculosis (TB) is caused by the obligate human pathogen, Mycobacterium tuberculosis.Mycobacteria are a distinctive rod shaped, non spore forming aerobic bacteria that share a common property of a lipid-rich cell-wall thatavidly retains carbol fushion dye in the presence of acidic alcohol (acid fast staining).Mycobacteria typically measures 0.5μm to 3μm. AIM AND OBJECTIVES: With the ongoing progress in protein crystallography and NMR, structurebaseddrug design is gaining increasing importance in the search for new drugs.Modeling starts from the 3D structure of a target protein in order to construct molecules which are complementary to a binding site, in their geometry as well as in the pattern of their physicochemical properties around the molecules The present study relates to the synthesis of various aryl carboxylic acid derivatives and subsequent screening for their anti-tubercular activity. Due to several toxic effects of isoniazid, attempts were made to eliminate the toxicophore and substituting with a group contributing to the anti-tubercular action. This work also aims the same motive and the compounds were synthesized according to the developed and valid syntheticroute. SUMMARY: 1. Decaprenylphosphoryl-b-d-ribose 2’-Epimerase 1(DprE1) a enzyme ofOxidoReductase family is a critical enzyme for the growth of Mycobacterium tuberculosis H37Rv.2. From the review of literature DprE1 was chosen for our study for drug design.3.A database of 100 molecules with high potential of inhibiting the target possessing PDB ID of 4FDO were carefully chosen by making changes to thelead molecule aryl carboxylic acid derivatives.4. The 3D structure of the molecules were docked against the 3D structure of DprE1 using the docking platform argus lab.5. Three compounds with good Docking score (lower Binding energy) were selected for laboratory synthesis. The reaction conditions were optimized.6. The Compounds were labeled as R1, R2, R3 were synthesized with satisfactory yield.7. The purity of the synthesized compounds was ensured by repeated recrystallization and column chromatography.Further the compounds were evaluated by melting point and TLC.8. The characterizations of the synthesized compounds were done by Infrared, Nuclear magnetic resonance and Mass spectroscopic methods.9. The final pure compounds were screened for Antimycobacterial activity by in vitro method called Microplate Alamar Blue Assay (MABA). 10. The synthesized compounds were active at 25mcg/ml to <100mcg/ml, which are compared to that of the known anti-tubercular agents at 50mcg/ml against the MIC of known TB drugs. The synthesized compounds were lesser activethan that of the standard TB drugs. Pyrazinamide: 3.125mcg/ml,Ciprefloxacin: 3.125mcg/ml and Streptomycin 6.25mcg/ml.11.The synthesized compounds were subjected to toxicity prediction assessments by OSIRS software. The results are coded as a green colour which confirmsthe drug likeness. CONCLUSION: Our work concludes that our synthesized molecules are effective in inhibitingDecaprenylphosphoryl-beta-D-ribose 2’-Epimerase 1(DprE1) which is important for the growth of Mycobacterium tuberculosis.Further structural refinement in the structure of the synthesized compounds will give new outlook to the development of promising molecules against thepathogen Mycobacterium tuberculosis." @default.
• W2891027998 created "2018-09-27" @default.
• W2891027998 creator A5051357411 @default.
• W2891027998 date "2016-04-01" @default.
• W2891027998 modified "2023-09-26" @default.
• W2891027998 title "Design, Synthesis, Characterization and Biological Evaluation of Some Novel Anti Tubercular Agents Targeting: Decaprenylphosphoryl-Beta-D-Ribose 2’Epimerase-1" @default.
• W2891027998 hasPublicationYear "2016" @default.
• W2891027998 type Work @default.
• W2891027998 sameAs 2891027998 @default.
• W2891027998 citedByCount "0" @default.
• W2891027998 crossrefType "dissertation" @default.
• W2891027998 hasAuthorship W2891027998A5051357411 @default.
• W2891027998 hasConcept C142724271 @default.
• W2891027998 hasConcept C159047783 @default.
• W2891027998 hasConcept C2777975735 @default.
• W2891027998 hasConcept C2780374374 @default.
• W2891027998 hasConcept C2780931024 @default.
• W2891027998 hasConcept C2781069245 @default.
• W2891027998 hasConcept C2908647359 @default.
• W2891027998 hasConcept C71924100 @default.
• W2891027998 hasConcept C86803240 @default.
• W2891027998 hasConcept C89423630 @default.
• W2891027998 hasConcept C99454951 @default.
• W2891027998 hasConceptScore W2891027998C142724271 @default.
• W2891027998 hasConceptScore W2891027998C159047783 @default.
• W2891027998 hasConceptScore W2891027998C2777975735 @default.
• W2891027998 hasConceptScore W2891027998C2780374374 @default.
• W2891027998 hasConceptScore W2891027998C2780931024 @default.
• W2891027998 hasConceptScore W2891027998C2781069245 @default.
• W2891027998 hasConceptScore W2891027998C2908647359 @default.
• W2891027998 hasConceptScore W2891027998C71924100 @default.
• W2891027998 hasConceptScore W2891027998C86803240 @default.
• W2891027998 hasConceptScore W2891027998C89423630 @default.
• W2891027998 hasConceptScore W2891027998C99454951 @default.
• W2891027998 hasLocation W28910279981 @default.
• W2891027998 hasOpenAccess W2891027998 @default.
• W2891027998 hasPrimaryLocation W28910279981 @default.
• W2891027998 hasRelatedWork W1972878636 @default.
• W2891027998 hasRelatedWork W1991575863 @default.
• W2891027998 hasRelatedWork W2117987331 @default.
• W2891027998 hasRelatedWork W2203855346 @default.
• W2891027998 hasRelatedWork W2335829128 @default.
• W2891027998 hasRelatedWork W2397877058 @default.
• W2891027998 hasRelatedWork W2408195322 @default.
• W2891027998 hasRelatedWork W2738906526 @default.
• W2891027998 hasRelatedWork W2769277562 @default.
• W2891027998 hasRelatedWork W2883684007 @default.
• W2891027998 hasRelatedWork W2884208101 @default.
• W2891027998 hasRelatedWork W2890293173 @default.
• W2891027998 hasRelatedWork W2941167399 @default.
• W2891027998 hasRelatedWork W2968134322 @default.
• W2891027998 hasRelatedWork W3010335444 @default.
• W2891027998 hasRelatedWork W3112214008 @default.
• W2891027998 hasRelatedWork W3113013835 @default.
• W2891027998 hasRelatedWork W3182059592 @default.
• W2891027998 hasRelatedWork W3203213455 @default.
• W2891027998 hasRelatedWork W2987339938 @default.
• W2891027998 isParatext "false" @default.
• W2891027998 isRetracted "false" @default.
• W2891027998 magId "2891027998" @default.
• W2891027998 workType "dissertation" @default.